HARDMAN JOHNSTON GLOBAL ADVISORS LLC – Vertex Pharmaceuticals Incorporated Transaction History
HARDMAN JOHNSTON GLOBAL ADVISORS LLC portfolio value:
$61.96M
portfolio value
HARDMAN JOHNSTON GLOBAL ADVISORS LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -7.72% | -17.91K shares | -3.38M | $289.54 | 214K |
Q2 2022 | share | Decrease | -5.34% | -13.09K shares | 1.41M | $281.79 | 231.91K |
Q1 2022 | share | Increase | +17.44% | 36.38K shares | 18.12M | $260.97 | 245.00K |
Q4 2021 | share | Increase | +10.57% | 19.95K shares | 11.59M | $222.45 | 208.62K |
Q3 2021 | share | Decrease | -1.82% | -3.50K shares | -4.52M | $181.39 | 188.67K |
Q2 2021 | share | Decrease | -2.05% | -4.01K shares | -3.41M | $201.63 | 192.17K |
Q1 2021 | share | Increase | +0.26% | 500 shares | -4.09M | $214.89 | 196.19K |
Q4 2020 | share | Decrease | -0.50% | -985 shares | -7.27M | $236.34 | 195.69K |
Q3 2020 | share | Decrease | -1.26% | -2.51K shares | -4.30M | $272.12 | 196.67K |
Q2 2020 | share | Decrease | -8.69% | -18.96K shares | 5.91M | $290.31 | 199.19K |
Q1 2020 | share | Decrease | -0.48% | -1.05K shares | 3.91M | $237.95 | 218.15K |
Q4 2019 | share | Decrease | -3.54% | -8.05K shares | 9.49M | $218.95 | 219.20K |
Q3 2019 | share | Decrease | -0.78% | -1.79K shares | -3.50M | $169.42 | 227.26K |
Q2 2019 | share | Decrease | -3.99% | -9.52K shares | -1.88M | $183.38 | 229.05K |
Q1 2019 | share | Decrease | -1.66% | -4.01K shares | 3.68M | $183.95 | 238.57K |
Q4 2018 | share | Decrease | -3.82% | -9.63K shares | -8.41M | $165.71 | 242.58K |
Q3 2018 | share | Decrease | -1.53% | -3.93K shares | 5.07M | $192.74 | 252.22K |
Q2 2018 | share | Increase | +35.60% | 67.25K shares | 12.74M | $169.96 | 256.15K |
Q1 2018 | share | Increase | 0.00% | 188.9K shares | 30.78M | $162.98 | 188.9K |